[Botulinum toxin A (BTX-A) point injection for treatment of the third lumbar transverse process syndrome].
OBJECTIVE
To observe clinical therapeutic effect of acupoint injection of botulinum toxin type A (BTX-A) on the third lumbar transverse process syndrome.


METHODS
Twenty-five cases of the third lumbar transverse process syndrome were randomly divided into 2 groups, an acupoint-injection group (n=10) and an acupuncture group (n=15). The acupoint-injection group were treated with acupoint injection of BTX-A into tender points at the third lumbar transverse process or surrounding acupoints, and the acupuncture group were treated with acupuncture at the same points as in the acupoint-injection group. Two months later, their therapeutic effects and the time of producing the effect were compared between the two groups.


RESULTS
The cured rate and the time of producing the effect were 50.0% and (3.75+/-1.65) days in the acupoint-injection group, and 0, (12.47+/-5.33) days in the acupuncture group, respectively, the former being better than the latter (P<0.05).


CONCLUSIONS
The clinical therapeutic effect of injection of BTX-A on the third lumbar transverse process syndrome is better than that of simple acupuncture.
Liu
Zhen
Z
Department of Rehabilitation Medicine, Lianyungang Municipal First People's Hospital, Jiangsu 222000, China.
D015669:Acupuncture Points; D000328:Adult; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008159:Lumbar Vertebrae; D008297:Male; D008875:Middle Aged; D013122:Spinal Diseases / Q000188:drug therapy*; D013577:Syndrome; D013997:Time Factors
D019274:Botulinum Toxins, Type A